Molecular mechanisms in retrovirus DNA integration

Antiviral Research

Volumn 36, Issue 3, 1997, Pages 139-156

  Asante Appiah, Ernest ^a   Skalka, Anna Marie ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Integrase; Integration; Retrovirus

Indexed keywords

1,3 BIS(5,7 HYDROXY 2 NAPHTHALENECARBOXAMIDO)PROPANE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; AROMATIC AMIDE; AURINTRICARBOXYLIC ACID; BETA CONINDENDROL; BIS NAPHTHOYLAMIDE DERIVATIVE; CAFFEIC ACID DERIVATIVE; CAFFEIC ACID PHENETHYL ESTER; CATECHOL DERIVATIVE; CICHORIC ACID; CURCUMIN; CYNARINE; FLAVONE DERIVATIVE; INTEGRASE; INTEGRASE INHIBITOR; INTERCALATING AGENT; LIGNAN; MONOCLONAL ANTIBODY; QUERCETAGENIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME;

AMINO TERMINAL SEQUENCE; AVIAN SARCOMA VIRUS; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CRYSTAL STRUCTURE; DNA BINDING; DNA INTEGRATION; DRUG DESIGN; ENZYME INHIBITION; ENZYME STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR BIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROVIRUS; REVIEW;

AVES; AVIAN SARCOMA VIRUS; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0031434606     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00046-6     Document Type: Article

References (127)

1. Aiyar A., Hindmarsh P., Skalka A.M., Leis J. Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J. Virol. 70:1996;3571-3580.
2. Allen P., Worland S., Gold L. Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. Virology. 209:1995;327-336.
3. Andrake M., Skalka A.M. Multimerization determinants reside in both the catalytic core and C-terminus of avian sarcoma virus integrase. J. Biol. Chem. 270:1995;29299-29306.
4. Andrake M., Skalka A.M. Retroviral integrases: putting the pieces together. J. Biol. Chem. 271:1996;19633-19636.
5. Asante-Appiah E., Skalka A.M. A metal-induced conformational change and activation in HIV-1 integrase. J. Biol. Chem. 272:1997;16196-16205.
6. Ariyoshi M., Vassylyev D.G., Iwasaki H., Nakamura H., Shinagawa H., Morikawa K. Atomic structure of Ruv C resolvase: a Holliday junction-specific endonuclease from E. coli. Cell. 78:1994;1063-1072.
7. Beese L.S., Steitz T.A. Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: a two-metal ion mechanism. EMBO J. 10:1991;25-33.
8. Bowerman B., Brown P.O., Bishop J.M., Varmus H.E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:1989;469-478.
9. Brown P.O., Bowerman B., Varmus H.E., Bishop J.M. Correct integration of retroviral DNA in vitro. Cell. 49:1987;347-356.
10. Bujacz G., Jaskólski M., Alexandratos J., Wlodawer A., Merkel G., Katz R.A., Skalka A.M. High resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253:1995;333-346.
11. Bujacz G., Jaskólski M., Alexandratos J., Wlodawer A., Merkel G., Katz R.A., Skalka A.M. The catalytic domain of avian sarcoma virus integrase: confirmation of the active site residues in the presence of divalent cations. Structure. 4:1995;89-96.
12. Bujacz G., Alexandratos J., Qing Z.L., Clement-Mella C., Wlodawer A. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Lett. 398:1996;175-178.
13. Bujacz G., Jaskólski M., Alexandratos J., Wlodawer A., Merkel G., Andrake M.A., Katz R.A., Skalka A.M. Binding of different divalent cations to the active site of ASV integrase and their effects on enzymatic activity. J. Biol. Chem. 272:1997;18161-18168.
14. Bukrinskaya A.G., Ghorpade A., Heinzinger N.K., Smithgall T.E., Lewis R.E., Stevenson M. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA. 93:1996;367-371.
15. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA. 89:1992;6580-6584.
16. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubei A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal with HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:1993;666-669.
17. Bukrinsky M.I., Sharova N., McDonald T.L., Pusharskaya T., Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA. 90:1993;6125-6129.
18. Burke C.J., Sanyal G., Bruner M.W., Ryan J.A., LaFemina R.L., Robbins H.L., Zeft A.S., Middaugh C.R., Cordingley M.G. Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase. J. Biol. Chem. 267:1992;9639-9644.
19. Bushman F.D., Craigie R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA. 88:1991;1339-1343.
20. Bushman F.D., Wang B. Rous sarcoma virus integrase: mapping functions for catalysis and substrate binding. J. Virol. 68:1994;2215-2223.
21. Cai M., Zheng R., Caffrey R., Clove M., Gronenborn A.M. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nature Struct. Biol. 4:1997;567-577.
22. Carteau S., Mouscadet J.F., Goulaouic H., Subra F., Auclair C. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochem. Biophys. Res. Commun. 192:1993;1409-1414.
23. Chow S.A., Vincent K.A., Ellison V., Brown P.O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus type. Science. 25:1992;723-726.
24. Colicelli J., Goff S.P. Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell. 42:1985;573-580.
25. Connell E.V., Hsu M.-C., Richman D.D. Combinative interactions of a human immunodeficiency virus (HIV) tat antagonist with reverse transcriptase inhibitors and HIV protease inhibitor. Antimicrob. Agents Chemother. 38:1994;348-352.
26. Craig J.C., Duncan J.B., Whitakker L., Roberts N.A. Antiviral synergy between inhibitors of HIV proteinase and reverse transcriptase. Antivir. Chem. Chemother. 4:1993;161-166.
27. Craigie R., Fujiwara T., Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell. 62:1990;829-837.
28. Craigie R. Hotspots and warm spots: integration specificity of retroelements. Trends Genet. 8:1992;187-190.
29. Cushman M., Sherman P. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 185:1992;85-90.
30. Cushman M., Golebiewski W.M., Pommier Y., Mazumder A., Reymen D., De Clerk E., Graham L., Rice W.G. Cosalene analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 38:1995;443-452.
31. Davies J.F. II, Hostomska Z., Hostomsky Z., Jordan S.R., Matthews D.A. Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science. 252:1991;88-95.
32. Dyda F., Hickman A.B., Jenkins T.M., Engelman A., Craigie R., Davies D.R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 266:1994;1981-1986.
33. Eich E., Pietz H., Kaloga M., Schultz J., Fesen M.R., Mazumder A., Pommier Y. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type 1 integrase. J. Med. Chem. 39:1996;86-95.
34. Eijkelenboom A.P.A.M., Puras-Lutzke R., Boelens R., Plasterk R.H.A., Kaptien R., Hürd K. The DNA binding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol. 2:1995;807-810.
35. Ellison V., Abrams H., Roe T., Lifson J., Brown P.O. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64:1990;2711-2715.
36. Ellison V., Brown P.O. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc. Natl. Acad. Sci. USA. 91:1994;7316-7320.
37. Ellison V., Gerton J., Vincent K.A., Brown P.O. An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer. J. Biol. Chem. 270:1995;3320-3326.
38. Engelman A., Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:1992;6361-6369.
39. Engelman A., Mizuuchi K., Craigie R. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell. 67:1992;1211-1221.
40. Engelman A., Bushman F.D., Craigie R. Identification of discreet functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J. 12:1993;3269-3275.
41. Engelman A., Hickman A.B., Craigie R. The core and C-terminal domains of the integrase from human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol. 68:1994;5911-5917.
42. Engelman A., Craigie R. Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J. Virol. 69:1995;5908-5911.
43. Engelman A., Ying L., Chen H., Farzan M., Dyda F. Structure-based mutagenesis of the catalytic domain of human immunodeficiency type 1 integrase. J. Virol. 71:1997;3507-3514.
44. Farnet C.M., Haseltine W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1991;1910-1915.
45. Farnet C.M., Bushman F.D. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell. 88:1997;483-492.
46. Fayet O., Ramond P., Polard P., Prére M.F., Chandler M. Functional similarities between retroviruses and the IS3 family of bacterial insertion sequences? Mol. Microbiol. 4:1990;1771-1777.
47. Fesen M.R., Kohn K.W., Lefeurtre F., Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc. Nat. Acad. Sci. USA. 90:1993;2399-2403.
48. Fesen M.R., Pommier Y., Leteurtre F., Hiroguchi S., Yung J., Kohn K. Inhibition of HIV-1 integrase by flavones, caffeic acid phenthyl ester (CAPE) and related compounds. Biochem. Pharm. 48:1994;595-608.
49. Fitzgerald M.L., Vora A.C., Zeh W.G., Grandgenett D.P. Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase. J. Virol. 66:1992;6257-6263.
50. Freed E.O., Martin M.A. HIV-1 infection of non-dividing cells. Nature. 369:1994;107-108.
51. Freed E.O., Englund G., Martin M.A. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69:1995;3949-3954.
52. Freed E.O., Englund G., Maldarelli F., Martin M.A. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell. 88:1997;171-174.
53. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80:1995;379-388.
54. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83:1995;569-576.
55. Goodarzi G., Im G.-J., Brackmann K., Grandgenett D.P. Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. J. Virol. 69:1995;6090-6097.
56. Goulaouic H., Chow S.A. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and E. coli Lex A protein. J. Virol. 70:1996;37-46.
57. Heinzinger N.K., Bukrinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.-A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
58. Hickman A.B., Palmer A., Engelman R., Craigie R., Wingfield P. Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase. J. Biol. Chem. 46:1994;29279-29287.
59. Hong T., Murphy E., Groarke J., Drlica K. Human immunodeficiency virus type 1 DNA integration: Fine structure target analysis using synthetic oligonucleotides. J. Virol. 67:1993;1127-1131.
60. Jenkins T.M., Engelman A., Ghirlando R., Craigie R. A soluble active mutant of HIV-1 integrase: multimerization involves the core and C-terminal domains. J. Biol. Chem. 271:1996;7712-7718.
61. Johnson M.S., McClure M.A., Feng D.-F., Gray J., Doolittle R.F. Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc. Natl. Acad. Sci. USA. 83:1986;7648-7652.
62. Johnson V.A., Walker B.D., Barhus M.A., Paradis T.J., Chou T.-C., Hirsch M.S. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3′-azido-3′-deoxythymidine. Antimicrob. Agents Chemother. 33:1989;53-57.
63. Jones K.S., Coleman J., Merkel G.W., Laue T.M., Skalka A.M. Retroviral integrase functions as a multimer and can turn over catalytically. J. Biol. Chem. 267:1992;16037-16040.
64. Kalpana G.V., Marmon S., Wang W., Crabtree G.R., Goff S.P. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science. 266:1994;2002-2006.
65. Katayanagi K., Okumura M., Morikawa K. Crystal structure of Escherichia coli RNase H1 in complex with Mg at 2.8 A resolution: proof of a single Mg-binding site. Prot. Struct. Func. Genet. 17:1993;337-346.
66. Katz R.A., Merkel G., Kulkosky J., Leis J., Skalka A.M. The avian retroviral IN protein is both necessary and sufficient for integration recombination in vitro. Cell. 63:1990;87-95.
67. Katz R.A., Merkel G., Skalka A.M. Targeting of retroviral integrase by a fusion to a heterologous DNA binding domain: ln vitro activities and incorporation of a fusion protein into viral particles. Virology. 217:1996;178-190.
68. Katzman M., Katz R.A., Skalka A.M., Leis J. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63:1989;5319-5327.
69. Katzman M., Sudol M. Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. J. Virol. 70:1996;9069-9073.
70. Kitamura Y., Lee Y.M., Coffin J.M. Nonrandom integration of retroviral DNA in vitro: effect of CpG methylation. Proc. Natl. Acad. Sci. USA. 89:1992;5532-5536.
71. Khan E., Mack J.P.G., Katz R.A., Kulkosky J., Skalka A.M. Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res. 19:1991;851-860.
72. Kukolj G., Skalka A.M. Enhanced and coordinated processing of viral DNA ends by retroviral integrates in vitro. Genes Dev. 9:1995;2556-2567.
73. Kukolj G., Jones K.S., Skalka A.M. Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. J. Virol. 71:1997;843-847.
74. Kulkosky J., Jones K.S., Katz R.A., Mack J.P.G., Skalka A.M. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12:1992;2331-2338.
75. Kulkosky J., Katz R.A., Merkel G., Skalka A.M. Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase. Virology. 206:1995;448-456.
76. LaFemina R.L., Callahan P.L., Cordingley M.G. Substrate specificity of recombinant human immunodeficiency virus type 1 integrase protein. J. Virol. 65:1991;5624-5630.
77. LaFemina R.L., Schneider C.L., Robbins H.L., Callahan P.L., LeGrow K., Roth E., Schleif W.A., Emini E.A. Requirement of active human immunodeficiency virus type 1 integrase enzyme for proactive infection of human T-lymphoid cells. J. Virol. 66:1992;7414-7419.
78. LaFemina R.L., Graham P.L., LeGrow K., Hastings J.C., Wolffe A., Young S.D., Emini E.A., Hazuda D. Inhibition of human immunodeficiency virus by bis-catechols. Antimicrob. Agents Chemother. 39:1995;320-324.
79. Leavitt A.D., Rose R.B., Varmus H.E. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae. J. Virol. 66:1992;2359-2368.
80. Lee Y.M.H., Coffin J.M. Efficient autointegration of avian retrovirus DNA in vitro. J. Virol. 64:1990;5624-5630.
81. Lee M.S., Craigie R. Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc. Natl. Acad. Sci. USA. 64:1994;5958-5965.
82. 2+-dependent 3′-processing activity for human immunodeficiency virus type 1 integrase in vitro real time kinetic studies using fluorescence resonance energy transfer. Biochemistry. 34:1995;10205-10214.
83. 2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry. 36:1997;173-180.
84. Levy-Mintz P., Duan L., Zhang H., Hu B., Dornadula G., Zhu M., Kulkosky J., Bizub-Bender D., Skalka A.M., Pomerantz R. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J. Virol. 70:1996;8821-8832.
85. Lipford J.R., Worland S.T., Farnet C.M. Nucleotide-binding by the HIV-1 integrase protein in vitro. J. AIDS. 7:1994;1215-1223.
86. Lodi P.J., Ernst J.A., Kuszewski J., Hickman A.B., Engelman A., Craigie R., Clore G.M., Gronenborn A.M. Biochemistry. 34:1995;9826-9833.
87. Mazumder A., Cooney D., Agbaria R., Gupta M., Pommier Y. Inhibition of human immunodeficiency virus type 1 by 3′-azido-3′-deoxythymidylate. Proc. Natl. Acad. Sci. USA. 91:1994;5771-5775.
88. Mazumder A., Raghavan K., Weinstein J., Kohn K.W., Pommier Y. Inhibition of human immunodeficiency virus type 1 integrase by curcumin. Biochem. Pharm. 49:1995;1165-1170.
89. Mazumder A., Neamati N., Ojwang J.O., Sunder S., Rando R.F., Pommier Y. Inhibition of human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry. 43:1996;13762-13771.
90. McEuen A.R., Edwards B., Koepke K.A., Ball A.E., Wolstenholme A.J., Danson M.J., Hough D.W. Zinc binding by retroviral integrase. Biochem. Biophys. Res. Commun. 189:1992;813-818.
91. Miller M.D., Farnet C.M., Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:1997;5382-5390.
92. Müller H.-P., Varmus H.E. DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J. 13:1994;4704-4714.
93. Murphy J.E., Goff S.P. A mutation at one end of Moloney murine leukemia virus DNA blocks cleavage of both ends by the viral integrase in vivo. J. Virol. 66:1992;5092-5095.
94. Ojwang J.O., Buckheit R.W., Pommier Y., Mazumder A., de Vresse K., Esté J.A., Reymen D., Pallansch L.A., Lackman-Smith C., Wallace T.L., deClercq E., McGrath M.S., Rando R.F. T30177, an aligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 39:1995;2426-2435.
95. Pahl A., Flügel R.M. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation, and by swapping the zinc finger domain of HIV-1. J. Biol. Chem. 270:1995;2957-2966.
96. Panganiban A.T., Temin H.M. The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature. 306:1983;155-160.
97. Pemberton I.K., Buckle M., Buc H. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits preference for Mn(II) rather than Mg(II). J. Biol. Chem. 271:1996;1498-1506.
98. Pryciak P.M., Sil A., Varmus H.E. Retroviral integration into minichromosomes in vitro. EMBO J. 11:1992;291-303.
99. Pryciak P.M., Varmus H.E. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell. 69:1992;769-780.
100. Puras-Lutzke R., Vink C., Plasterk R.H.A. Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res. 22:1994;4125-4131.
101. Puras-Lutzke R.A., Eppens N.A., Weber P.A., Houghten R.A., Plasterk R.H.A. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc. Natl. Acad. Sci. USA. 92:1995;11456-11460.
102. Rice P., Mizuuchi K. Structure of the bacteriophage Mu transposase core: a common structural motif for DNA transposition and retroviral integration. Cell. 82:1995;209-220.
103. Rice P., Craigie R., Davies D.R. Retroviral integrases and their cousins. Curr. Opin. Struct. Biol. 6:1996;76-83.
104. Robinson W.E. Jr., Reinecke M.G., Abdel-Malek S., Chow S.A. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA. 93:1996;6326-6331.
105. Roe T., Reynolds T.C., Yu G., Brown P.O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:1993;2099-2108.
106. Roe T., Chow S.A., Brown P.O. 3′-End processing and kinetics of 5′-end joining during retroviral integration in vivo. J. Virol. 71:1997;1334-1340.
107. Roth M.J., Schwartzenberg P.L., Goff S.P. Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence of IN function and terminal DNA sequence. Cell. 58:1989;47-54.
108. Roth M.J., Schwartzenberg P.L., Tanese N., Goff S.P. Analysis of mutations in the integration reactions of Maloney murine leukemia virus: effect on DNA binding and cutting. J. Virol. 64:1990;4709-4717.
109. Scottoline B.P., Chow S.A., Ellison V., Brown P.O. Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev. 11:1997;371-382.
110. Scourgen F., Maroun R.G., Frére V., Bouziane M., Anclair C., Troalen F., Fermandjian S. A synthetic peptide from the human immunodeficiency virus type 1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results. Eur. J. Biochem. 240:1996;765-773.
111. Sherman P.A., Fyfe J.A. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc. Natl. Acad. Sci. USA. 87:1990;5119-5123.
112. Shibagaki Y., Holmes M.L., Appa R.S., Chow S.A. Characterization of feline immunodeficiency virus integrase and analysis of functional domains. Virology. 230:1997;1-10.
113. Shih C.-C., Stoye J.P., Coffin J.M. Highly preferred targets for retrovirus integration. Cell. 53:1988;531-537.
114. Skalka, A.M., 1988. Integrative recombination of retroviral DNA. In: Kucherlapati, R., Smith, R. (Eds.), Genetic recombination. American Society for Microbiology, Washington, DC, pp. 701-724.
115. Steitz T.A., Smerdon S.J., Jager J., Joyce C.M. A unified polymerase mechanism for nonhomologous DNA and RNA polymerases. Science. 266:1994;2022-2025.
116. Stevenson M. Portals of entry: uncovering HIV nuclear transport pathways. Trends Cell Biol. 6:1996;9-15.
117. van den Ent F.M., Vink C., Plasterk R.H. DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J. Virol. 68:1994;7825-7832.
118. van Gent D.C., Vink C., Oude Groeneger A.A.M., Plasterk R.H.A. Complementation between HIV integrase proteins mutated in different domains. EMBO J. 12:1993;3261-3268.
119. Varmus, H.E., Brown, P.O., 1989. Retroviruses. In: Berg, D.E., Howe, M.M. (Eds.), Mobile DNA. American Society for Microbiology, Washington, DC, pp. 53-108.
120. Vincent K.A., Ellison V., Chow S.A., Brown P.O. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J. Virol. 67:1993;425-437.
121. Vink C., van Gent D.C., Elgersma Y., Plasterk R.H.A. Human immunodeficiency virus type 1 integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J. Virol. 65:1991;4636-4644.
122. Von Schwedler U., Kombluth R.S., Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescient T lymphocytes. Proc. Natl. Acad. Sci USA. 91:1994;6992-6996.
123. Vora A.C., McCord M., Fitzgerald M.L., Inman R.B., Grandgenett D.P. Efficient concerted integration of retrovirus-like DNA in vitro by avian retrovirus integrase. Nucleic Acids Res. 22:1994;4454-4461.
124. Wolfe A.L., Felock P.J., Hastings J.C., Blau C.U., Hazuda D.J. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates. J. Virol. 70:1996;1424-1432.
125. Yang W., Steitz T.A. Recombining the structures of HIV integrase, Ruv C and RNase H. Structure. 3:1995;88-95.
126. Zhao H., Neamati N., Mazumder A., Sunder S., Pommier Y., Burke T.R. Arylamide inhibitors of HIV-1 integrase. J. Med. Chem. 40:1997;1186-1194.
127. Zheng R., Jenkins T.M., Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization and enhances activity. Proc. Natl. Acad. Sci. USA. 93:1996;13644-13659.